Task: Answer the multiple choice question.
Question: Which drug exhibits a 16.712% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CC1C/C(=N\NC(N)=S)c2cc(Cl)ccc2S1
b COC(=O)c1ccc(N2NC(=O)/C(=C/c3cc(OC)c(O)c(OC)c3)C2=O)cc1
c O=C(NC1CCCCCCC1)c1cccs1
Answer: b. COC(=O)c1ccc(N2NC(=O)/C(=C/c3cc(OC)c(O)c(OC)c3)C2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)c1ccc(N2NC(=O)/C(=C/c3cc(OC)c(O)c(OC)c3)C2=O)cc1
COC(=O)c1ccc(N2NC(=O)/C(=C/c3cc(OC)c(O)c(OC)c3)C2=O)cc1
methyl 4-[(4Z)-4-[(4-hydroxy-3,5-dimethoxyphenyl)methylidene]-3,5-dioxopyrazolidin-1-yl]benzoate